Kanker kandung kemih Dokter Terbaik di Israel - TOP-17 dokter

Dr. Sarid memimpin Departemen Onkologi di Sourasky Medical Center, yang berspesialisasi dalam kanker kandung kemih dengan pengobatan inovatif seperti imunoterapi dan terapi target.

• Onkolog senior sejak 1997, kepala departemen sejak 2009
• Fellowship dalam urologi kanker di Universitas Oxford
• Peneliti utama dalam uji klinis untuk terapi kanker baru
• Menerbitkan lebih dari 30 artikel tentang pengobatan kanker
• Anggota ESMO, ASCO, dan perkumpulan onkologi Israel

Prof. Merimsky memimpin Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center dengan pengalaman lebih dari 30 tahun di bidang onkologi ortopedi.

• Associate Professor Onkologi di Fakultas Kedokteran Sackler
• Fellowship dalam pengobatan sarkoma di Institut Gustave Roussy, Paris
• Anggota aktif ESMO Sarcoma Faculty dan ASCO
• Menerbitkan penelitian ekstensif tentang kanker tulang dan jaringan lunak

Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.

She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.

Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Stepfansky memimpin unit rawat inap onkologi di Sourasky Medical Center Israel yang terkenal, dengan keahlian mendalam dalam perawatan berbasis rumah sakit.

• Lebih dari 20 tahun pengalaman medis, spesialisasi dalam onkologi dan penyakit dalam
• Keterlibatan penelitian klinis yang luas dalam uji coba onkologi fase pertama hingga ketiga
• Peneliti utama pada berbagai studi onkologi tingkat lanjut
• Spesialisasi dalam manajemen pasien kanker rawat inap yang kompleks

Prof. Jack Baniel melakukan rekonstruksi kandung kemih dan operasi kanker dengan teknik nerve-sparing di Rabin Medical Center. Ia mendirikan Departemen Onkourologi di Rumah Sakit Beilinson.

• Menerbitkan lebih dari 100 artikel ilmiah tentang uro-onkologi
• Menjadi anggota asosiasi urologi Eropa dan Amerika
• Berpartisipasi dalam penelitian klinis global
• Menjadi Profesor Urologi dengan peran kepemimpinan

Dr. Hughes Hyun berspesialisasi dalam bedah robotik dan invasif minimal untuk kanker kandung kemih di Sourasky Medical Center.

• Ahli bedah bersertifikat dengan pengalaman luas
• Berfokus pada teknik robotik tingkat lanjut
• Praktik di salah satu pusat medis terkemuka di Israel

Prof. Jablonski-Perec menempuh pelatihan di Sloan-Kettering Cancer Center – salah satu institusi onkologi terkemuka di dunia – dan mengepalai Institut Onkologi di Hadassah Medical Center.

• Memimpin Pusat Perawatan Kanker Payudara sejak 1998
• Profesor Onkologi di Hebrew University
• Anggota dari beberapa komunitas kanker internasional
• Menerima beasiswa dari Hadassah Medical School

Profesor Gofrit memiliki sertifikasi untuk melakukan bedah robotik untuk kanker urologi. Ia memimpin Departemen Urologi di Hadassah Medical Center.

• Menyelesaikan pelatihan onkologi urologi khusus di Chicago, AS
• Meneliti dan mengobati kanker kandung kemih dan ginjal secara khusus
• Mengajar bedah urologi di Hebrew University
• Memegang penghargaan nasional dan internasional atas karyanya di bidang urologi
• Spesialisasi dalam bedah endoskopi dan bantuan robot da Vinci

dr. Yutkin memiliki lebih dari 20 tahun pengalaman dalam diagnosis dan pengobatan di Hadassah Medical Center.

• Lulus dari Fakultas Kedokteran Hebrew University of Jerusalem
• Spesialisasi dalam gangguan sendi temporomandibular
• Lancar berbahasa Inggris, Ibrani, dan Rusia

Urologist, Surgeon

Dr. Amiel adalah Kepala Departemen Urologi di Rambam Medical Center, yang berfokus pada bedah kanker. Perannya menunjukkan keahlian mendalam dalam kasus-kasus urologi yang kompleks.

• Spesialisasi sebagai ahli bedah onkologi untuk kanker sistem urin
• Memberikan perawatan di rumah sakit universitas besar di Israel

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Spesialis onkourologi – berfokus secara eksklusif pada kanker kandung kemih di Assuta Medical Center.

• Ahli urologi dengan keahlian mendalam dalam pengobatan kanker kandung kemih
• Bekerja di Assuta Medical Center – fasilitas onkologi terkemuka
• Berdedikasi pada onkourologi, memastikan perawatan khusus

Ahli radioterapi yang berspesialisasi dalam pengobatan kanker kandung kemih di Assuta Medical Center.

• Spesialisasi dalam terapi radiasi
• Memiliki pengalaman mengobati berbagai kondisi onkologi
• Mempraktikkan pendekatan pengobatan berbasis bukti

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.